MENU
RPRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Royalty Pharma (RPRX) Earnings Date & Reports

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties... Show more

A.I. Advisor
published Earnings

RPRX is expected to report earnings to rise 5.98% to $1.24 per share on February 17

Royalty Pharma RPRX Stock Earnings Reports
Q4'25
Est.
$1.24
Q3'25
Beat
by $0.18
Q2'25
Beat
by $0.10
Q1'25
Missed
by $0.66
Q4'24
Missed
by $0.63
The last earnings report on November 05 showed earnings per share of $1.17, beating the estimate of 99 cents. With 2.25M shares outstanding, the current market capitalization sits at 16.91B.
View a ticker or compare two or three
RPRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RPRX showed earnings on November 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a provider of drug development services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
110 East 59th Street
Phone
+1 212 883-0200
Employees
89
Web
https://www.royaltypharma.com